At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
Cavilon Advanced Barrier Filmdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Evaluation of 3M Cavilon Advanced Barrier Film for the Treatment of Incontinence Associated Dermatitis (IAD)
In Brief
A clinical study evaluating Cavilon Advanced Barrier Film for Dermatitis. Completed, enrolled 16 participants.
Detailed Summary
The purpose of this study is to obtain information concerning the safety and effective use of a protective barrier film in patients experiencing severe incontinence associated dermatitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDermatitis
Countries--
Collaborators3M
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartAug 2014
Primary CompletionFeb 2015
First PostedMar 2016
TodayJul 2026
First PostedMar 31, 2016
Enrollment StartAug 1, 2014
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.3 years ago
Interventions
Cavilon Advanced Barrier Filmdevice
Cavilon Advanced Barrier Fim's application applied twice a week